Aratana Therapeutics, Inc. (PETX)
(Delayed Data from NSDQ)
$4.75 USD
+0.11 (2.37%)
Updated May 3, 2019 04:00 PM ET
After-Market: $4.76 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
[PETX]
Reports for Purchase
Showing records 1 - 17 ( 17 total )
Industry: Medical - Drugs
Industry: Medical - Drugs
Elanco to Acquire Aratana for $245M in Stock; Downgrade to Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Industry: Medical - Drugs
Continued Revenue Growth Expected in 2019; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Industry: Medical - Drugs
Strong Revenues Driven by Galliprant Sales; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Industry: Medical - Drugs
ValuEngine Detailed Valuation Report for PETX
Provider: ValuEngine, Inc
Industry: Medical - Drugs
Nocita Approved for Cats; Strong Revenue Growth in 2Q18; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Industry: Medical - Drugs
Nocita and Entyce Continue to Grow; Potential AT-003 Approval 2H18; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Industry: Medical - Drugs
Entyce Posts Strong Intial Sales; New Products in 2018; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Industry: Medical - Drugs
Three Notable Areas of Development in Companion Animal Health; Our Takeaways from VMX 2018
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Industry: Medical - Drugs
Galliprant Approved in EU; Additional Product Approvals Expected in 2018; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Industry: Medical - Drugs
AT-014 Conditional Approval: Further Attestation to Strategy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Industry: Medical - Drugs
A Commercial Stage Animal Health Biotech with a Proven Development Model; Initiate with Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Industry: Medical - Drugs
A New Wave of Biotechs Reshaping the Animal Health Market; Initiate Coverage on Aratana and Kindred Bio With Buy Ratings
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Industry: Medical - Drugs
A Wind of Change Is Blowing Through the Animal Health Market
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Industry: Medical - Drugs
Aratana reported on Monday that the Center for Veterinary Medicine
Provider: DAWSON JAMES SECURITIES, INC.
Industry: Medical - Drugs
A new era is underway in companion animal therapeutics and more specifically in the blending of companion animal, comparative biology/oncology and human health
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: GRISEWOOD S
Industry: Medical - Drugs
Comparative Oncology: A New Breed of Trial Set to Improve Clinical Success in Oncology
Provider: DAWSON JAMES SECURITIES, INC.
|